Asserter profile

AVENUE CAPITAL MANAGEMENT II, L.P.

operating company2 patents now2 ever0 cases filed during tenure1 connections

PTAB exposure

2of this entity’s patents have been challenged at PTAB (2 total proceedings). 2 currently have active proceedings.

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Navenue_capital_management_ii["AVENUE CAPITAL MANAGEMENT II, L.P."]
    Nspruce_biosciences["SPRUCE BIOSCIENCES, INC."]
    Nspruce_biosciences -->|"2026 · Security Interest · 12576084"| Navenue_capital_management_ii
    Nspruce_biosciences -->|"2026 · SECURITY AGREEMENT · 12569491"| Navenue_capital_management_ii
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Navenue_capital_management_ii focal
    class Nspruce_biosciences operating

Patents currently held (2)

Connected entities (1)

Correspondent attorneys (2)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.